Clinical Trial Update: A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke [NA]

View source ↗

Summary

A Yonsei University-sponsored clinical trial evaluated MEMO Patch PLUS for detecting atrial fibrillation in individuals aged 75 or older or at high risk of stro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: Yonsei University | Conditions: Atrial Fibrillation/Flutter in Patients With High Risk of Stroke | NA | Status: COMPLETED